This inventor holds 8 USPTO granted patents and 1 EPO patent. Top assignees: The Translational Genomics Research Institute, Mayo Foundation for Medical Education and Research, Dignity Health. Active years: 2011-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tempe, AZ (US) (2011 - 2019)
- Phoenix, AZ (US) (2016 - 2020)
Company Filing History:
7 out of 124 
3 out of 1,808 
2 out of 185 
Years Active: 2011-2020
Title: Harshil Dineshkumar Dhruv: Innovator in Cancer Treatment
Introduction
Harshil Dineshkumar Dhruv is a prominent inventor based in Tempe, AZ (US), known for his significant contributions to cancer treatment technologies. With a total of 8 patents to his name, he has made remarkable strides in the field of medical research, particularly in the treatment of glioma.
Latest Patents
Among his latest patents, Dhruv has developed methods of sensitizing a patient with glioma to therapeutic agents by administering small hairpin RNA targeting PDZ-RHOGEF. This innovative technology encompasses methods of treating patients with cancer, such as glioblastoma. The methods may include the administration of one or more pharmaceutical compositions capable of inhibiting TROY to effectively treat the patient with cancer. Additionally, he has patented methods used to treat cancer, which also focus on the administration of pharmaceutical compositions that inhibit TROY.
Career Highlights
Throughout his career, Dhruv has worked with esteemed organizations such as the Translational Genomics Research Institute and the Mayo Foundation for Medical Education and Research. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Nhan L Tran and Joseph C Loftus, who have played significant roles in his research endeavors.
Conclusion
Harshil Dineshkumar Dhruv's innovative work in cancer treatment showcases his dedication to improving patient outcomes through advanced medical technologies. His contributions are paving the way for new therapeutic approaches in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile